Aquavit Celebrates Judgment Imposing Permanent Ban On Counterfeiters
NEW YORK, Nov. 3, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") secured a long-awaited and much-deserved judgment...
Search
Aquavit Pharmaceuticals, Inc. Names Timothy Sherwood Chief Operating Officer
NEW YORK, May 17, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") today announced that it has appointed Senior Vice...
AAD, Industry Collab to Increase Number of Black,Latino, and Indigenous Physicians in Dermatology
Volume 19, No. 4 • April 2022
Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin
NEW YORK, March 24, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. announced today that it has submitted its IND package...
Aquavit Further Prevails Against Counterfeiters in U.S. Following its Recent Victory in Europe
NEW YORK , March 21, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc ("Aquavit") continues to succeed in its intellectual property...
Aquavit's AQV-1122 COVID-19 Vaccine Patent Approval Fast Tracked by USPTO
September 1, 2021; New York, NY Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a...
Patent Granted to Aquavit for Novel RoA and MoA for Bioactive Compositions
May 4, 2021; New York, NY U.S. patent number 10,980,865 [Application Number 14/909,954] was granted to Aquavit Pharmaceuticals, Inc. for...
Aquavit to Introduce A New Botulinum Toxin (DTX-021)
NEW YORK, April 14, 2021 Aquavit Holdings LLC announced today that it acquired an exclusive license to register, market and commercialize...
New Vitamin Supplement Compositions Patent Granted by USPTO
March 19, 2021: New York, NY Aquavit Pharmaceuticals, Inc. (“Aquavit”) announced today that the United States Patent and Trademark Office...
Dr. Sten Vermund, Dean, Yale School of Public Health Congratulates Aquavit Pharmaceuticals
About Dr. Sten Vermund: Dr. Sten Vermund is a pediatrician and infectious disease epidemiologist focused on diseases of low and middle...
Aquavit Wins Trademark Case over AQUAGOLD in European Union Intellectual Property Office
April 15, 2021: New York, NY The European Union Intellectual Property Office (EUIPO) declared that U-BioMed’s falsely registered...
The New Normal: Protect Yourself with Face Masks, & Protect Your Skin with the InnerB System® Mask
NEW YORK, Dec. 2, 2020 We are now living in the "new-normal" era, wearing face masks everywhere. With the extended use of face coverings,...
Aquavit files patent for an innovative method for delivering exosomes using microchannel technology
October 15, 2020: New York, NY Aquavit filed a new patent application with the United States Patent and Trademark Office. The patent...
Aquavit Pharmaceuticals, Inc. Wins Default Judgement Against Counterfeiter
September 08, 2020: New York, NY Aquavit Pharmaceuticals, Inc. ("Aquavit") won a default judgement against counterfeiter in the United...
Aquavit Files For New COVID-19 Self-Administrable Vaccine Delivery Method and Technology Patent
August 18, 2020: New York, NY Aquavit Files For New COVID-19 Self-Administrable Vaccine Delivery Method and Technology Patent Through...
Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters
August 13, 2020: New York, NY Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters for...
Aquavit files patent for a unique method to treat Macular Degeneration
July 1, 2020; New York, NY Aquavit has filed a new patent application with the United States Patent and Trademark Office. The patent...
Aquavit Unveils Its Platform Technology Addressing COVID-19 at 2020 BIO International Conference
June 08, 2020: New York, NY Aquavit Pharmaceuticals Unveils Its Platform Technology Addressing COVID-19 at 2020 BIO International...
New Drug Delivery Platform and Immunotherapeutic Compositions Against Cancer
April 15, 2020: New York, NY New Drug Delivery Platform and Immunotherapeutic Compositions Against Cancer Using Proprietary Microchannel...